Personalized medicine for individuals with Down sy... [Mol Genet Metab. 2011] - PubMed result

Mol Genet Metab. 2011 Jul 19. [Epub ahead of print]
Personalized medicine for individuals with Down syndrome.
McCabe LL, McCabe ER.
SourceLinda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, USA; Center for Bioethics and Humanities, University of Colorado School of Medicine, USA; Department of Pediatrics, University of Colorado School of Medicine, USA.

Abstract
As the cost of whole genome analysis decreases, we have the opportunity to explore the interactions of various gene changes in an individual that lead to their particular phenotype. This will provide the ability to move from the epidemiologic study of groups, in which, the individuals are treated collectively and homogenously, to personalized medicine, and a model in which the individual is recognized and treated as a distinct entity. We will be applying personalized medicine to individuals with Down syndrome in order to understand and develop biomarkers for increased risk of co-morbidities. Personalized medicine will change the "culture of intractability" of Down syndrome.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:21807541[PubMed - as supplied by publisher]
Personalized medicine for individuals with Down sy... [Mol Genet Metab. 2011] - PubMed result